Efficacy And Safety Of Elbasvir/Grazoprevir In A Large Real-Life Cohort Of Hcv-Infected Patients Martina Gambato , Angiola Spinetti , Luisa Pasulo , Roberta D'Ambrosio , Massimo Puoti , Monica Schiavini , Paolo Fabris , Paolo Sacchi , Roberto Gulminetti , Giada Carolo , Piergiorgio Scotton , Caterina Pozzan , Maria Vinci , Mauro Vigano , Salvatore Lobello , Massimo Giovanni Zuin , Alessio Aghemo , Maria Grazia Rumi , Maurizio Carrara , Vinicio Manfrin , Caterina Uberti-Foppa , Sandro Panese , Francesca Cattelan , Veronica Paon , Angelo Pan , Ombretta Spinelli , Antonella D'Arminio Monforte , Agostino Colli , Giancarlo Spinzi , Francesco Paolo Russo , Liliana Chemello , Valter Vincenzi , Paolo Antonio Grossi , Elisabetta Buscarini , Giovanna Cardaci , Alessandro Soria , Barbara Menzaghi , Monia Mendeni , Elisabetta Degasperi , Roberta Soffredini , Maria Colpani , Laura Comi , Valentina Zuccaro , Serena Zaltron , G. Andrea , Paolo Del Poggio , Alessia Giorgini , Andrea Capretti , Massimo Memoli , Marie Graciella Pigozzi , Maria Cristina Rossi , Luisa Cavalletto , Franco Capra , Alberto Colombo , Clara Dibenedetto , Simona Landonio , Franco Noventa , Pietro Lampertico , Francesco Castelli , Alfredo Alberti , Stefano Fagiuoli DIGESTIVE AND LIVER DISEASE（2019）
Abstract
Introduction: The efficacy and safety of Elbasvir/Grazoprevir (E/G) among patients with Hepatitis C Virus (HCV) chronic infection have been mainly investigated in clinical trials, and scarce real-life data are available yet.
More Translated text
Key words
elbasvir/grazoprevir, elbasvir/grazoprevir, real-life, hcv-infected
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
